D-Glucose

From NuGOwiki

(Redirected from HMDB00122)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

D-Glucose
2D structure for D-Glucose
Chemical Name (3R,4R,5S,6S)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
Chemical Formula C6H12O6
CAS Number 50-99-7
Chemical Information HMDB00122
Biochemical Taxonomy Not Available
Functional Taxonomy Not Available
Nutritional Taxonomy

  • Carbohydrates

Metabolic Pathways

  • Alanine and Aspartate Metabolism
  • Arginine and D-Ornithine Metabolism
  • Glyoxylate and Dicarboxylate Metabolism
  • Pyruvate Metabolism

Biofluid Location

  • Blood
  • Breast Milk
  • Cerebrospinal Fluid (CSF)
  • Saliva
  • Urine

Tissue Location

  • Adrenal Cortex
  • Adrenal Gland
  • Adrenal Medulla
  • Beta Cell
  • Bladder
  • Brain
  • Brain Plaques
  • Epidermis
  • Eye Lens
  • Fetus
  • Fibroblasts
  • Gonads
  • Gut
  • Intestine
  • Kidney
  • Liver
  • Lung
  • Mouth
  • Muscle
  • Myelin
  • Nerves
  • Neurons
  • Pancreas
  • Pla
  • Placenta
  • Adipose Tissue

Normal Biofluid Concentrations

  • Blood: 12000.0 +/- 4440.0 uM
  • Blood: 2200.0 (1100.0-3300.0) uM
  • Blood: 2750.0 (2200.0-3300.0) uM
  • Blood: 4440.0 +/- 100.0 uM
  • Blood: 4440.0 +/- 370.0 uM
  • Blood: 4450.0 (3300.0 - 5600.0) uM
  • Blood: 4470.0 +/- 346.0 uM
  • Blood: 4570.0 +/- 411.0 uM
  • Blood: 4750.0 +/- 184.0 uM
  • Blood: 5181.0 +/- 394.0 uM
  • Blood: 5300 (4900-5700) uM
  • Blood: 5350.0 +/- 120.0 uM
  • Blood: 5400.0 (4700.0-6100.0) uM
  • Blood: 5450.0 (4200.0 - 6700.0) uM
  • Breast Milk: 4500.0+/- 100.0 uM
  • Cerebrospinal Fluid (CSF): 1720.0 (1560.0-1880.0) uM
  • Cerebrospinal Fluid (CSF): 2960 +/- 1110 uM
  • Cerebrospinal Fluid (CSF): 5390.0 +/- 1650.0 uM
  • Saliva: >10 uM
  • Urine: > 0.65 umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Acute myelogenous leukemia (AML)
  • Dementia of Alzheimer type (DAT)
  • Diabetes
  • Diabetic ketosis
  • Exercise
  • Glucoglycinuria
  • Hyperlipidaemics not on pharmacological treatment

Other (Monogenic Disorders)

Abnormal Biofluid Concentrations

  • Blood (Acute myelogenous leukemia (AML)): 6000.0 (5000.0-6800.0) uM
  • Blood (Exercise): 4470.0 +/- 110.0 uM
  • Blood (Hyperlipidaemics not on pharmacological treatment): 5114.0 +/- 483.0 uM
  • Cerebrospinal Fluid (CSF) (Dementia of Alzheimer type (DAT)): 3700.0 (3200.0-4200.0) uM
  • Urine (Diabetes): 19700.0 umol/mmol creatinine
  • Urine (Diabetic ketosis): 79.6 umol/mmol creatinine
  • Urine (Diabetic ketosis): 79600.0 (68300.0-90900.0) umol/mmol creatinine
  • Urine (Glucoglycinuria): umol/mmol creatinine

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Glucose is a monosaccharide containing six carbon atoms and an aldehyde group and is therefore referred to as an aldohexose. The glucose molecule can exist in an open-chain (acyclic) and ring (cyclic) form, the latter being the result of an intramolecular reaction between the aldehyde C atom and the C-5 hydroxyl group to form an intramolecular hemiacetal. In water solution both forms are in equilibrium and at pH 7 the cyclic one is the predominant. Glucose is a primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. In animals glucose arises from the breakdown of glycogen in a process known as glycogenolysis. Glucose is synthesized in the liver and kidneys from non-carbohydrate intermediates, such as pyruvate and glycerol, by a process known as gluconeogenesis.

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Acute myelogenous leukemia (AML)
  • Dementia of Alzheimer type (DAT)
  • Diabetes
  • Diabetic ketosis
  • Exercise
  • Glucoglycinuria
  • Hyperlipidaemics not on pharmacological treatment

Other (Monogenic) Disorders

guidelines

Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines